Isotretinoin
( DrugBank: Isotretinoin / KEGG DRUG: Isotretinoin )
4 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 36 | Epidermolysis bullosa | 1 |
| 39 | Toxic epidermal necrolysis | 1 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 159 | Xeroderma pigmentosum | 1 |
| 160 | Congenital ichthyosis | 2 |
36. Epidermolysis bullosa
Clinical trials : 197 / Drugs : 223 - (DrugBank : 46) / Drug target genes : 53 - Drug target pathways : 136
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
39. Toxic epidermal necrolysis
Clinical trials : 17 / Drugs : 22 - (DrugBank : 10) / Drug target genes : 11 - Drug target pathways : 103
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
159. Xeroderma pigmentosum
Clinical trials : 12 / Drugs : 16 - (DrugBank : 5) / Drug target genes : 7 - Drug target pathways : 17
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
160. Congenital ichthyosis
Clinical trials : 63 / Drugs : 93 - (DrugBank : 22) / Drug target genes : 21 - Drug target pathways : 144
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|